NGR-hTNF in combination with best investigator choice in previously treated malignant pleural mesothelioma (NGR015): a randomised,double-blind,placebo-controlled phase 3 trial |
| |
| Authors: | Vanesa Gregorc,Rabab M Gaafar,Adolfo Favaretto,Francesco Grossi,Jacek Jassem,Andreas Polychronis,Paolo Bidoli,Marcello Tiseo,Riyaz Shah,Paul Taylor,Silvia Novello,Alberto Muzio,Alessandra Bearz,Laurent Greillier,Floriana Fontana,Giulia Salini,Antonio Lambiase,Mary O&#x Brien |
| |
| Affiliation: | 1. Ospedale San Raffaele, Milan, Italy;2. National Cancer Institute, University, Cairo, Egypt;3. Istituto Oncologico Veneto, Padua, Italy;4. Ospedale Policlinico San Martino, Genoa, Italy;5. Medical University, Gdansk, Poland;6. Mount Vernon Cancer Centre, Northwood, UK;7. Ospedale San Gerardo, Monza, Italy;8. Azienda Ospedaliero-Universitaria, Parma, Italy;9. Kent Oncology Centre, Maidstone, UK;10. Wythenshawe Hospital, Manchester, UK;11. University of Turin, AOU San Luigi, Orbassano, Turin, Italy;12. Ospedale S Spirito, Casale Monferrato, Italy;13. Centro di Riferimento Oncologico, Aviano, Italy;14. Assistance Publique Hôpitaux de Marseille, Aix Marseille University, Marseille, France;15. MolMed, Milan, Italy;p. The Royal Marsden Hospital, Sutton, UK |
| |
| Abstract: | ![]()
|
| |
| Keywords: | Correspondence to: Dr Vanesa Gregorc Ospedale San Raffaele Via Olgettina 60 20132 Milan Italy |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
